Private Advisor Group
AVXL icon

Private Advisor Group’s Anavex Life Sciences AVXL Stock Holding History

Private Advisor Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$873K Sell
432,000
-72,000
-14% -$199K ﹤0.01% 1753
2026
Q2 		$1.31M Buy
504,000
+4,300
+0.9% +$12.7K 0.01% 1224
2026
Q1 		$1.53M Buy
499,700
+79,900
+19% +$346K 0.01% 1174
2025
Q4 		$1.49M Sell
419,800
-35,325
-8% -$216K 0.01% 1172
2025
Q3 		$4.05M Buy
455,125
+55,900
+14% +$567K 0.02% 703
2025
Q2 		$3.68M Buy
399,225
+184,500
+86% +$1.57M 0.02% 692
2025
Q1 		$1.84M Buy
214,725
+184,800
+618% +$1.75M 0.01% 935
2024
Q4 		$321K Sell
29,925
-17,488
-37% -$135K ﹤0.01% 1814
2024
Q3 		$269K Buy
47,413
+4,442
+10% +$25.6K ﹤0.01% 2018
2024
Q2 		$181K Buy
42,971
+46
+0.1% +$186 ﹤0.01% 2172
2024
Q1 		$218K Buy
42,925
+1,945
+5% +$10.9K ﹤0.01% 2061
2023
Q4 		$382K Sell
40,980
-1,850
-4% -$12.7K ﹤0.01% 1636
2023
Q3 		$281K Buy
42,830
+11,150
+35% +$88.7K ﹤0.01% 1663
2023
Q2 		$258K Sell
31,680
-7,500
-19% -$64.3K ﹤0.01% 1718
2023
Q1 		$336K Sell
39,180
-78,700
-67% -$786K ﹤0.01% 1516
2022
Q4 		$1.09K Sell
117,880
-16,800
-12% -$179K ﹤0.01% 1229
2022
Q3 		$1.39M Sell
134,680
-51,800
-28% -$547K 0.02% 766
2022
Q2 		$1.87M Buy
186,480
+63,225
+51% +$599K 0.02% 787
2022
Q1 		$1.52M Buy
+123,255
New +$1.52M 0.01% 915
2020
Q3 		– Sell
-3,000
Closed -$15K – 1712
2020
Q2 		$15K Buy
+3,000
New +$11.3K ﹤0.01% 2710

Other funds holding AVXL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Apella Capital
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Private Advisor Group's AVXL Position: Q3 2026 in Review

Private Advisor Group reduced its Anavex Life Sciences (AVXL) stake by 14% in Q3 2026, selling an estimated $199K and leaving 432,000 shares worth $873K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Private Advisor Group first reported a position in AVXL in Q2 2020 and has held it in 20 quarters since. The position peaked at $4.05M in Q3 2025. 89 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Private Advisor Group held 432,000 shares of Anavex Life Sciences worth $873K as of Q3 2026.
  • Private Advisor Group sold 72,000 Anavex Life Sciences shares in Q3 2026, an estimated $199K.
  • Anavex Life Sciences made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #1753 holding.
  • Private Advisor Group first reported a position in Anavex Life Sciences in Q2 2020 and has held it in 20 quarters since.
  • Private Advisor Group's Anavex Life Sciences position peaked at $4.05M in Q3 2025.
  • 89 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.